GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Cyclically Adjusted PS Ratio

Aarti Drugs (BOM:524348) Cyclically Adjusted PS Ratio : 2.05 (As of May. 16, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Cyclically Adjusted PS Ratio?

As of today (2024-05-16), Aarti Drugs's current share price is ₹480.20. Aarti Drugs's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹234.08. Aarti Drugs's Cyclically Adjusted PS Ratio for today is 2.05.

The historical rank and industry rank for Aarti Drugs's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:524348' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.52   Med: 2.24   Max: 3.5
Current: 1.97

During the past years, Aarti Drugs's highest Cyclically Adjusted PS Ratio was 3.50. The lowest was 1.52. And the median was 2.24.

BOM:524348's Cyclically Adjusted PS Ratio is ranked better than
53.95% of 747 companies
in the Drug Manufacturers industry
Industry Median: 2.17 vs BOM:524348: 1.97

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Aarti Drugs's adjusted revenue per share data for the three months ended in Mar. 2024 was ₹67.438. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹234.08 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Aarti Drugs Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Aarti Drugs's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Cyclically Adjusted PS Ratio Chart

Aarti Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.28 1.58 1.85

Aarti Drugs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 2.09 2.40 2.11 1.85

Competitive Comparison of Aarti Drugs's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Drugs's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aarti Drugs's Cyclically Adjusted PS Ratio falls into.



Aarti Drugs Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Aarti Drugs's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=480.20/234.08
=2.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarti Drugs's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Aarti Drugs's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=67.438/153.2548*153.2548
=67.438

Current CPI (Mar. 2024) = 153.2548.

Aarti Drugs Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 26.803 94.103 43.651
201409 29.512 96.780 46.733
201412 26.800 96.780 42.439
201503 29.857 97.163 47.093
201506 29.240 99.841 44.883
201509 28.158 101.753 42.410
201512 27.348 102.901 40.731
201603 32.427 102.518 48.475
201606 30.081 105.961 43.507
201609 32.518 105.961 47.032
201612 30.670 105.196 44.682
201703 31.322 105.196 45.631
201706 27.063 107.109 38.723
201709 33.449 109.021 47.020
201712 35.151 109.404 49.240
201803 35.057 109.786 48.937
201806 39.319 111.317 54.132
201809 36.810 115.142 48.994
201812 40.311 115.142 53.654
201903 48.688 118.202 63.126
201906 43.162 120.880 54.722
201909 51.245 123.175 63.759
201912 50.806 126.235 61.681
202003 48.244 124.705 59.289
202006 58.441 127.000 70.522
202009 62.029 130.118 73.059
202012 56.894 130.889 66.616
202103 53.836 131.771 62.614
202106 62.630 134.084 71.584
202109 62.594 135.847 70.615
202112 68.553 138.161 76.042
202203 74.975 138.822 82.770
202206 67.166 142.347 72.313
202209 74.185 144.661 78.592
202212 71.702 145.763 75.387
202303 80.174 146.865 83.662
202306 71.394 150.280 72.807
202309 69.518 151.492 70.327
202312 65.910 153.255 65.910
202403 67.438 153.255 67.438

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aarti Drugs  (BOM:524348) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Aarti Drugs Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Drugs (BOM:524348) Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines